30 December 2025 : Original article
Impact of COVID-19 on Kidney Transplant Outcomes: An 8-Year Study From the Czech Republic
Jan Roman ABDEF 1,2, František Jalůvka BDEF 1,2*, Petr Jelínek
DEF 1,2, Petr Ostruszka BF 1, Ján Hrubovčák DEF 1,2, Pavel Havránek ABD 1,3, Adéla Kondé CE 4,5, Zdeněk Lys BCE 3, Martin Drápela ABEF 3, Vaclav Prochazka AEF 2,6
DOI: 10.12659/AOT.950961
Ann Transplant 2025; 30:e950961
Table 1 Donor baseline and paraclinical characteristics.
| Median (IQR) or n (%)* | P** | ||
|---|---|---|---|
| Before COVID-19 (n=94) | COVID-19 pandemic (n=44) | ||
| 51 (42; 58) | 51 (35; 57) | 0.436 | |
| 75 (69; 85) | 75 (64; 86) | 0.969 | |
| 24.7 (23.2; 27.6) | 24.7 (21.9; 27.5) | 0.458 | |
| 1.91 (1.77; 2.04) | 1.92 (1.75; 2.07) | 0.706 | |
| 47 (50.0) | 30 (68.2) | 0.069 | |
| 70 (74.5) | 17 (38.6) | ||
| 87.5 (65.2; 113.8) | 76.5 (54.5; 104.0) | 0.181 | |
| *** | 1.29 (0.94; 1.71) | 1.62 (1.05; 1.77) | |
| 0.17 (0.08; 0.49) | 0.15 (0.06; 0.37) | 0.257 | |
| 190 (116; 257) | 196 (136; 231) | 0.895 | |
| 0.065 | |||
| Yes | 36 (48.6) | 13 (29.5) | |
| No | 38 (51.4) | 31 (70.5) | |
| Unknown | 20 | --- | |
| >0.999 | |||
| Yes | 6 (8.5) | 3 (6.8) | |
| No | 65 (91.5) | 41 (93.2) | |
| Unknown | 23 | --- | |
| 0.239 | |||
| Yes | 7 (9.9) | 1 (2.3) | |
| No | 64 (90.1) | 43 (97.7) | |
| Unknown | 23 | --- | |
| >0.999 | |||
| Yes | 3 (4.2) | 2 (4.5) | |
| No | 68 (95.8) | 42 (95.5) | |
| Unknown | 23 | --- | |
| * The median with the interquartile range (Q1–Q3) or the absolute frequency and relative frequency (%). ** The value of the Mann-Whitney test, chi-square test of independence for contingency tables, or Fisher’s exact test. *** eGFR – Estimated glomerular filtration rate from the creatinine concentration. | |||